Deep EndometriosisENDO-3DNCT07864883
3D Modeling of Deep Endometriosis From Pelvic MRI
An observational study of Deep Endometriosis, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
This retrospective monocentric study aims to assess the feasibility and clinical relevance of three-dimensional (3D) modeling of deep endometriosis lesions derived from pelvic MRI. The study evaluates whether 3D reconstruction improves surgical planning and multidisciplinary management. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Deep Endometriosis
- How many people
- 60 participants
- Where
- 1 siteFrance
- Study dates
- 27 Oct 2025to 27 Feb 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Study population: Women with surgically managed deep endometriosis and available preoperative pelvic MRI at Strasbourg University Hospital.
Who may be able to join
- Patient aged 18 years or older
- Confirmed diagnosis of deep endometriosis
- Available and interpretable preoperative pelvic MRI
- Surgical management performed at Strasbourg University Hospital between 01/01/2020 and 12/31/2022
- No documented opposition to reuse of medical data
Who cannot join
- Patient opposition to data reuse
- Patient younger than 18 years
- Incomplete medical records preventing MRI-3D-surgery comparison
- Poor quality or non-interpretable MRI
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service de Gynécologie - CHU de Strasbourg - France
Strasbourg, 67091
Lise Lecointre, MD, PhD, 33 3 88 12 74 72, lise.lecointre@chru-strasbourg.fr
Lise Lecointre, MD, PhD
About this study
Official title: Three-Dimensional Modeling of Deep Endometriosis From Pelvic MRI
This retrospective monocentric study aims to assess the feasibility and clinical relevance of three-dimensional (3D) modeling of deep endometriosis lesions derived from pelvic MRI. The study evaluates whether 3D reconstruction improves surgical planning and multidisciplinary management.
- Conditions
- Deep Endometriosis
- Keywords
- Endometriosis, Magnetic Resonance Imaging, 3D Modeling
- Medical subject headings
- Endometriosis
What is being measured
The primary outcome is the main question the study is designed to answer.
Impact of 3D modeling on surgical planning
Evaluation of whether 3D reconstruction modifies or confirms the surgical strategy compared to standard MRI interpretation
Measured: From January 1, 2020 to December 31, 2022
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2026
- Study start27 Oct 2025
- Primary completion27 Dec 2026 (estimated)
- Study completion27 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Deep EndometriosisStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07864883
- Sponsor's protocol ID
- RC25_0064
- Acronym
- ENDO-3D
- Status last verified
- Oct 2026
- First submitted
- 2 Oct 2026
- Last updated
- 8 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Three-Dimensional Modeling of Deep Endometriosis From Pelvic MRI
- ClinicalTrials.gov ID
- NCT07864883
- Acronym / sponsor ID
- ENDO-3D / RC25_0064
- Conditions
- Deep Endometriosis
- Keywords
- Endometriosis, Magnetic Resonance Imaging, 3D Modeling
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 27 Oct 2025 (actual)
- Primary completion
- 27 Dec 2026 (estimated)
- Study completion
- 27 Feb 2027 (estimated)
- First posted
- 8 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This retrospective monocentric study aims to assess the feasibility and clinical relevance of three-dimensional (3D) modeling of deep endometriosis lesions derived from pelvic MRI. The study evaluates whether 3D reconstruction improves surgical planning and multidisciplinary management.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Women with surgically managed deep endometriosis and available preoperative pelvic MRI at Strasbourg University Hospital.
Key inclusion criteria (5 listed)
- Patient aged 18 years or older
- Confirmed diagnosis of deep endometriosis
- Available and interpretable preoperative pelvic MRI
- Surgical management performed at Strasbourg University Hospital between 01/01/2020 and 12/31/2022
- No documented opposition to reuse of medical data
Key exclusion criteria (4 listed)
- Patient opposition to data reuse
- Patient younger than 18 years
- Incomplete medical records preventing MRI-3D-surgery comparison
- Poor quality or non-interpretable MRI
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Impact of 3D modeling on surgical planning
Time frame: From January 1, 2020 to December 31, 2022
Evaluation of whether 3D reconstruction modifies or confirms the surgical strategy compared to standard MRI interpretation
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Oct 2026.
Related trials for Deep Endometriosis
Not yet recruitingObservational study
Clinical Impact of Ultrasound Diagnosis in Bowel Endometriosis
Endometriosis, Endometriosis Rectum
RecruitingObservational study
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
Endometriosis
Recruiting
Prospective Trial of [18F]AlF-FAPI-74 for PET Imaging of Fibroblast Activation Protein in Patients With Endometriosis
Endometriosis, Deep Infiltrating Endometriosis
RecruitingObservational study
Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms
Adenomyosis of Uterus
RecruitingObservational study
Artificial Intelligence Into Ultrasound Diagnostics in Reproductive Medicine
Endometriosis, Adenomyosis of Uterus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Deep Endometriosis, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Lise Lecointre, MD, PhD (33 3 88 12 74 72, lise.lecointre@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Impact of 3D modeling on surgical planning (time frame: From January 1, 2020 to December 31, 2022). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.